Staci Sudenga, Ph.D.

Profile

None provided

Publications

The following timeline graph is generated from all co-authored publications.

1. Concordance of Beta-papillomavirus across anogenital and oral anatomic sites of men: The HIM Study. Nunes EM, López RVM, Sudenga SL, Gheit T, Tommasino M, Baggio ML, Ferreira S, Galan L, Silva RC, Lazcano-Ponce E, Giuliano AR, Villa LL, Sichero L, HIM Study group (2017) Virology : 55-59
   › Primary publication · 28708973 (PubMed) · PMC6561082 (PubMed Central)
2. Patterns of prevalent HPV and STI co-infections and associated factors among HIV-negative young Western Cape, South African women: the EVRI trial. Menezes LJ, Pokharel U, Sudenga SL, Botha MH, Zeier M, Abrahamsen ME, Glashoff RH, Engelbrecht S, Schim van der Loeff MF, van der Laan LE, Kipping S, Taylor D, Giuliano AR (2018) Sex Transm Infect 94(1): 55-61
   › Primary publication · 28490581 (PubMed) · PMC6561095 (PubMed Central)
3. HPV SEROSTATUS PRE- AND POST-VACCINATION IN A RANDOMIZED PHASE II PREPAREDNESS TRIAL AMONG YOUNG WESTERN CAPE, SOUTH AFRICAN WOMEN: THE EVRI TRIAL. Sudenga SL, Torres BN, Botha MH, Zeier M, Abrahamsen ME, Glashoff RH, Engelbrecht S, Schim Van der Loeff MF, Van der Laan LE, Kipping S, Taylor D, Giuliano AR (2017) Papillomavirus Res : 50-56
   › Primary publication · 28480334 (PubMed) · PMC5417542 (PubMed Central)
4. Comparison of the Natural History of Genital HPV Infection among Men by Country: Brazil, Mexico, and the United States. Sudenga SL, Torres BN, Silva R, Villa LL, Lazcano-Ponce E, Abrahamsen M, Baggio ML, Salmeron J, Quiterio M, Giuliano AR (2017) Cancer Epidemiol Biomarkers Prev 26(7): 1043-1052
   › Primary publication · 28446543 (PubMed) · PMC5556383 (PubMed Central)
5. HPV-related external genital lesions among men residing in Brazil. da Silva RJC, Sudenga SL, Sichero L, Baggio ML, Galan L, Cintra R, Torres BN, Stoler M, Giuliano AR, Villa LL (2017) Braz J Infect Dis 21(4): 376-385
   › Primary publication · 28399426 (PubMed) · PMC6561086 (PubMed Central)
6. Comparison of anal HPV natural history among men by country of residence: Brazil, Mexico, and the United States. Sudenga SL, Nyitray AG, Torres BN, Silva R, Villa L, Lazcano-Ponce E, Abrahamsen M, Baggio ML, Salmeron J, Quiterio M, Giuliano AR (2017) J Infect 75(1): 35-47
   › Primary publication · 28363585 (PubMed) · PMC6640845 (PubMed Central)
7. Seroprevalence of cutaneous human papillomaviruses (HPVs) among men in the multinational HPV Infection in Men study. Rahman S, Pierce Campbell CM, Waterboer T, Rollison DE, Ingles DJ, Torres BN, Michel A, Sudenga SL, Pawlita M, Villa LL, Lazcano Ponce E, Borenstein AR, Wang W, Giuliano AR (2016) J Gen Virol 97(12): 3291-3301
   › Primary publication · 27902363 (PubMed) · PMC5756495 (PubMed Central)
8. Country-specific HPV-related genital disease among men residing in Brazil, Mexico and The United States: The HIM study. Sudenga SL, Torres BN, Fulp WJ, Silva R, Villa LL, Lazcano-Ponce E, Ingles DJ, Stoler M, Messina JL, Abrahamsen M, Baggio ML, Salmeron J, Quiterio M, Giuliano AR (2017) Int J Cancer 140(2): 337-345
   › Primary publication · 27681815 (PubMed) · PMC5687823 (PubMed Central)
9. An analysis of HPV infection incidence and clearance by genotype and age in men: The HPV Infection in Men (HIM) Study. Ingles DJ, Lin HY, Fulp WJ, Sudenga SL, Lu B, Schabath MB, Papenfuss MR, Abrahamsen ME, Salmeron J, Villa LL, Ponce EL, Giuliano AR (2015) Papillomavirus Res : 126-135
   › Primary publication · 27547836 (PubMed) · PMC4986989 (PubMed Central)
10. Impact of Serum Antibodies to HPV Serotypes 6, 11, 16, and 18 to Risks of Subsequent Genital HPV Infections in Men: The HIM Study. Pamnani SJ, Sudenga SL, Viscidi R, Rollison DE, Torres BN, Ingles DJ, Abrahamsen M, Villa LL, Lazcano-Ponce E, Salmeron J, Quiterio M, Huang Y, Borenstein A, Giuliano AR (2016) Cancer Res 76(20): 6066-6075
    › Primary publication · 27535333 (PubMed) · PMC5065769 (PubMed Central)
11. Diversity of beta-papillomavirus at anogenital and oral anatomic sites of men: The HIM Study. Nunes EM, Sudenga SL, Gheit T, Tommasino M, Baggio ML, Ferreira S, Galan L, Silva RC, Pierce Campbell CM, Lazcano-Ponce E, Giuliano AR, Villa LL, Sichero L, HIM Study group (2016) Virology : 33-41
    › Primary publication · 27161202 (PubMed) · PMC4949595 (PubMed Central)
12. Seroconversion Following Anal and Genital HPV Infection in Men: . Giuliano AR, Viscidi R, Torres BN, Ingles DJ, Sudenga SL, Villa LL, Baggio ML, Abrahamsen M, Quiterio M, Salmeron J, Lazcano-Ponce E (2015) Papillomavirus Res : 109-115
    › Primary publication · 26688833 (PubMed) · PMC4680989 (PubMed Central)
13. Cervical HPV natural history among young Western Cape, South African women: The randomized control EVRI Trial. Sudenga SL, Torres BN, Botha MH, Zeier M, Abrahamsen ME, Glashoff RH, Engelbrecht S, Schim Van der Loeff MF, Van der Laan LE, Kipping S, Taylor D, Giuliano AR (2016) J Infect 72(1): 60-9
    › Primary publication · 26476151 (PubMed) · PMC4698060 (PubMed Central)
14. Genital Human Papillomavirus Infection Progression to External Genital Lesions: The HIM Study. Sudenga SL, Ingles DJ, Pierce Campbell CM, Lin HY, Fulp WJ, Messina JL, Stoler MH, Abrahamsen M, Villa LL, Lazcano-Ponce E, Giuliano AR (2016) Eur Urol 69(1): 166-73
    › Primary publication · 26051441 (PubMed) · PMC4670812 (PubMed Central)
15. High HIV, HPV, and STI prevalence among young Western Cape, South African women: EVRI HIV prevention preparedness trial. Giuliano AR, Botha MH, Zeier M, Abrahamsen ME, Glashoff RH, van der Laan LE, Papenfuss M, Engelbrecht S, Schim van der Loeff MF, Sudenga SL, Torres BN, Kipping S, Taylor D (2015) J Acquir Immune Defic Syndr 68(2): 227-35
    › Primary publication · 25415290 (PubMed) · PMC4378717 (PubMed Central)
16. Functional variants in CYP1A1 and GSTM1 are associated with clearance of cervical HPV infection. Sudenga SL, Shrestha S, Macaluso M, Partridge EE, Johanning GL, Piyathilake CJ (2014) Gynecol Oncol 135(3): 560-4
    › Primary publication · 25281494 (PubMed) · PMC4268049 (PubMed Central)
17. EUROGIN 2014 roadmap: differences in human papillomavirus infection natural history, transmission and human papillomavirus-related cancer incidence by gender and anatomic site of infection. Giuliano AR, Nyitray AG, Kreimer AR, Pierce Campbell CM, Goodman MT, Sudenga SL, Monsonego J, Franceschi S (2015) Int J Cancer 136(12): 2752-60
    › Primary publication · 25043222 (PubMed) · PMC4297584 (PubMed Central)
18. Alternative dosage schedules with HPV virus-like particle vaccines. Stanley MA, Sudenga SL, Giuliano AR (2014) Expert Rev Vaccines 13(8): 1027-38
    › Primary publication · 25001893 (PubMed) · PMC4147727 (PubMed Central)
19. Dense genotyping of immune-related loci identifies variants associated with clearance of HPV among HIV-positive women in the HIV epidemiology research study (HERS). Sudenga SL, Wiener HW, King CC, Rompalo AM, Cu-Uvin S, Klein RS, Shah KV, Sobel JD, Jamieson DJ, Shrestha S (2014) PLoS One 9(6): e99109
    › Primary publication · 24918582 (PubMed) · PMC4053382 (PubMed Central)
20. Role and uptake of human papillomavirus vaccine in adolescent health in the United States. Sudenga SL, Royse KE, Shrestha S (2011) Adolesc Health Med Ther 2011(2): 63-74
    › Primary publication · 24155627 (PubMed) · PMC3804132 (PubMed Central)
21. Variants in interleukin family of cytokines genes influence clearance of high risk HPV in HIV-1 coinfected African-American adolescents. Sudenga SL, Wiener HW, Shendre A, Wilson CM, Tang J, Shrestha S (2013) Hum Immunol 74(12): 1696-700
    › Primary publication · 23973891 (PubMed) · PMC3842375 (PubMed Central)
22. Knowledge, attitudes, practices, and perceived risk of cervical cancer among Kenyan women: brief report. Sudenga SL, Rositch AF, Otieno WA, Smith JS (2013) Int J Gynecol Cancer 23(5): 895-9
    › Primary publication · 23694983 (PubMed) · PMC3662490 (PubMed Central)
23. Key considerations and current perspectives of epidemiological studies on human papillomavirus persistence, the intermediate phenotype to cervical cancer. Sudenga SL, Shrestha S (2013) Int J Infect Dis 17(4): e216-20
    › Primary publication · 23453716 (PubMed) · PMC3602330 (PubMed Central)
24. Incidence, prevalence, and epidemiology of herpes simplex virus-2 in HIV-1-positive and HIV-1-negative adolescents. Sudenga SL, Kempf MC, McGwin G, Wilson CM, Hook EW, Shrestha S (2012) Sex Transm Dis 39(4): 300-5
    › Primary publication · 22421698 (PubMed) · PMC3306602 (PubMed Central)
25. Transitional probability-based model for HPV clearance in HIV-1-positive adolescent females. Kravchenko J, Akushevich I, Sudenga SL, Wilson CM, Levitan EB, Shrestha S (2012) PLoS One 7(1): e30736
    › Primary publication · 22292027 (PubMed) · PMC3265500 (PubMed Central)
26. The impact of highly active antiretroviral therapy on prevalence and incidence of cervical human papillomavirus infections in HIV-positive adolescents. Shrestha S, Sudenga SL, Smith JS, Bachmann LH, Wilson CM, Kempf MC (2010) BMC Infect Dis : 295
    › Primary publication · 20946655 (PubMed) · PMC2965148 (PubMed Central)

Keywords & MeSH Terms

MeSH terms are retrieved from PubMed records. Learn more.

Key: MeSH Term Keyword